Načítá se...
DDIS-03. HARNESSING siRNA NANOMEDICINE FOR THERAPEUTIC GENE SILENCING IN GLIOBLASTOMA
GBM is the most common primary brain tumor in adults, with a very poor prognosis. Despite tremendous efforts to develop new drugs, the treatment of GBM remains a great challenge. The use of nanoparticles (NPs) has emerged as a potential strategy for diagnosis and treatment of tumors, GBM especially....
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692115/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.239 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|